Evidence map›Paper›PMID 40906698›Full record

ArticlePloS one2025

Hemoglobin response to iron-folic acid supplementation and associated factors among anemic pregnant women attending the University of Gondar Comprehensive Specialized Hospital ANC ward Northwest, Ethiopia 2023: A longitudinal follow up study.

Asefu Fekadie, Bisrat Birke Teketelew, Melak Aynalem, Aregawi Yalew

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asefu FekadieDepartment of Hematology and Immunohematology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Bisrat Birke TeketelewDepartment of Hematology and Immunohematology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.ORCID https://orcid.org/0000-0002-7980-5172
Melak AynalemDepartment of Hematology and Immunohematology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Aregawi YalewDepartment of Hematology and Immunohematology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnemia is the most frequent complication during pregnancy. Iron and folate deficiencies are the primary causes of anemia during pregnancy resulting from low hemoglobin concentration. Globally, preventive strategies such as iron and folic acid supplementation, improved dietary practice and deworming program play a crucial role in reducing the rate of anemia. Hemoglobin is improved as a result of iron-folic acid supplementation, though some factors affect good response. Due to limited studies to the study area, the main aim of this study was to assess the hemoglobin response to iron-folic acid supplementation and associated factors among anemic pregnant women. As iron and folic acid supplementation is the key intervention to reduce maternal and fetal complication, this study provides critical insights into the effectiveness of the intervention on improving hemoglobin level and can inform global maternal health strategies, particularly in resource limed settings where anemia remains a major public health concern.

methodsA longitudinal follow up study was conducted on a total of 357 anemic pregnant women at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia from June to October 2023. Simple random sampling technique was employed to select the study participants. Data were collected using pretested structured questionnaires. Hemoglobin was determined using Sysmex kx21n hematological analyze. Direct wet mount examination was performed to determine intestinal parasites. Moreover, serological tests were screened using rapid test kit immunochromatographic technique. Data was entered in to Epi-data version 4.6 software and exported to SPSS version 20 for analyses. Paired sample t-test was utilized to determine the change in hemoglobin. Both bi-variable and multivariable logistic regression were done to determine factors associated with the poor response of iron folic acid supplementation. A p-value of < 0.05 was considered as statistically significant.

resultsThe overall good hemoglobin response after IFA supplementation was 188/357 (52.7%). The median (IQR) of Hb was increased from 10.3 (9.6-10.49) gm/dL at baseline to 10.73 (9.78-12.0) gm/dL. Factors associated with poor hemoglobin response were residence (AOR = 2.4, 95% CI: 1.1 5.2), duration of IFA supplementation (AOR = 2.2,95% CI: 1.2, 3.7), intestinal parasite (AOR = 2.8, 95% CI: 1.3, 6.3), meat feeding habit less than two times per week (AOR = 1.7, 95% CI: 1.04, 2.9), green leaf vegetable and fruit feeding habit less than two times per week (AOR = 2.5,95% CI: 1.4, 4.0), coffee drinking habit (AOR = 1.9, 95% CI: 1.14, 3.3), parity (multiparous) (AOR = 2.9, 95% CI: 1.09, 7.2), HBsAg & HCV (AOR = 2.5, 95 CI: 1.15, 5.8) and stage of pregnancy (AOR = 4.0 95% CI (1.9,8.7). These factors in this study, showed significant association with poor hemoglobin responses.

conclusionHemoglobin level changed significantly from base line to end line. In this study, less than half of the study participants had poor hemoglobin response due to the aforementioned factors. Therefore, focused policies, health care facilitators and providers should strengthen efforts to provide information and create awareness about the benefits of iron and folic acid supplementation during pregnancy.

Indexed as

AnemiaDietary SupplementsFolic AcidHemoglobinsIronPregnancy Complications, HematologicAdolescentAdultEthiopiaFemaleFollow-Up StudiesHumansLongitudinal StudiesPregnancyYoung AdultFolic AcidHemoglobinsIron

Identifiers

PMID40906698
PMCPMC12410736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.